2 five-star stocks to buy

Altium Limited (ASX:ALU) and this ASX share could be five-star stocks to buy right now. Here's what you need to know about them…

| More on:

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you looking for some new additions to your portfolio? Then you might want to consider the two fantastic ASX shares named below.

They could be among the best shares available to investors on the Australian share market and capable of generating strong returns for investors over the next decade. Here's why they might be five-star stocks:

Altium Limited (ASX: ALU)

The first five-star stock to consider buying is Altium. It is a leading electronic design software provider which has exposure to the rapidly growing Internet of Things and artificial intelligence markets. As these markets are underpinning the proliferation of electronic devices globally, demand for software subscriptions looks set to increase materially over the next decade.

In addition to this, Altium's other businesses, such as workflow solution platform NEXUS and electronic parts search engine Octopart, are supporting it growth and have sizeable market opportunities of their own. A testament to the quality of NEXUS is that it counts Tesla and SpaceX as customers.

Given the favourable industry tailwinds and its leadership position, Altium appears well-placed to achieve its revenue target of US$500 million in FY 2025/26. This will be more than double what it expects to achieve in FY 2021.

Analysts at Morgan Stanley are positive on the company and have an overweight rating and $37.00 price target on its shares.

CSL Limited (ASX: CSL)

Another five-star stock to consider is CSL. This biotherapeutics giant is easily one of the highest quality companies that Australia has ever produced.

When it was founded all the way back in 1916 as the Commonwealth Serum Laboratories, the company was aiming to service the needs of a nation isolated by war. Since then it has become a global giant with a portfolio of life-saving therapies and vaccines.

In fact, that portfolio continues to grow thanks to the company's investment in research and development. Each year CSL invests somewhere in the region of 10% to 12% of its sales revenue back into its these activities. This helps to ensure that CSL is at the forefront of innovation in the industry.

And while the pandemic has negatively impacted its CSL Behring business, some of this is being offset by increased demand for flu vaccines from its Seqirus business.

Once the pandemic passes and plasma collection headwinds ease, both sides of the business will be pulling together again. Combined with potential launches of new and lucrative therapies, the future looks bright for CSL.

Last month Credit Suisse upgraded CSL's shares to an outperform rating with a $315.00 price target.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends Altium. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Growth Shares

3 unstoppable ASX shares to buy and hold for the next decade

These shares are going places over the remainder of the decade and beyond.

Read more »

Four piles of coins, each getting higher, with trees on them.
Growth Shares

2 high-growth ASX shares to buy today: brokers

These stocks have a strong growth outlook.

Read more »

Two university students in the library, one in a wheelchair, log in for the first time with the help of a lecturer.
Growth Shares

2 top-quality ASX shares to buy for beginner investors

These stocks could be a great place to start investing.

Read more »

A man in full American NFL playing kit crouches over with his arms across his chest in a defensive stance against a dark background.
Growth Shares

Here's why these two ASX 300 shares are great ones to own

These businesses are two of the fastest-growing stocks in the ASX 300 and are liked by fund manager WAM.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Growth Shares

3 ASX growth shares you'll wish you bought in June

Analysts think these shares could be destined for big things in the future.

Read more »

Father and daughter with hands on a small plant.
ETFs

Focused on growth? Here are 3 ASX ETFs to consider

Growth investors must ignore the current market noise about tariffs and focus on the long-term horizon.

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Growth Shares

Top brokers name 3 top ASX growth shares to buy now

Why are brokers feeling bullish on these names? Let's find out.

Read more »

Two plants grow in jars filled with coins.
Growth Shares

3 ASX 200 growth stocks up more than 100% in 1 year that could charge higher

It's been a memorable year for shareholders of these 3 companies.

Read more »